Panwar J

No ORCID on file · 1 paper in corpus
2026
·doi:10.21203/rs.3.rs-8424074/v1

Abstract Elagolix sodium is a novel, orally active non-peptide GnRH receptor antagonist used to treat endometriosis and uterine fibroids, as a BCS class III drug, it exhibits high solubility but low permeability, leading to poor and vari…